Charles River Laboratories International, Inc.CRLNYSE

|||

Overview Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Analyst Sentiment

Analysts lean bullish — 67% recommend buying.

Consensus Rating

Buy

24 analysts·High coverage

67%

Rating Distribution

Strong Buy

00%

Buy

1667%

Hold

833%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see modest upside — consensus target 13% higher.

Bear Case

$185.00

-2%

Consensus

$214.43

+13%

Bull Case

$260.00

+37%

Price Range24 analysts

Low

Consensus

High

$185.00

$260.00

Current Target

Current Price

$189.21

Upside to Target

$25.22

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$10.99(9 analysts)

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev+4.95%

EPS+10.30%

FY2028

Rev+3.17%

EPS+9.72%

FY2029

Rev+2.40%

EPS+4.78%

Earnings Surprises

Beat rate:100%(12/12 quarters)

Avg surprise:+10.0%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Jan 13, 2026Robert W. Baird

Charles River price target raised to $231 from $224 at Baird

Target:$231.00

+4.2%from $221.69

Jan 13, 2026Evercore ISI

Charles River price target raised to $260 from $250 at Evercore ISI

Target:$260.00

+15.5%from $225.11

Jan 9, 2026Robert W. Baird

Charles River price target raised to $224 from $199 at Baird

Target:$224.00

+2.1%from $219.49

Jan 9, 2026Mizuho Securities

Charles River price target raised to $215 from $200 at Mizuho

Target:$215.00

-0.2%from $215.51

Dec 18, 2025Mizuho Securities

Charles River price target raised to $200 from $174 at Mizuho

Target:$200.00

+2.1%from $195.98

Dec 15, 2025Barclays

Charles River price target raised to $215 from $210 at Barclays

Target:$215.00

+11.4%from $192.97

Dec 1, 2025Morgan Stanley

Morgan Stanley Assumes Charles River Labs (CRL) at Equalweight

Target:$185.00

+5.1%from $176.09

Nov 17, 2025Argus Research

Charles River upgraded to Buy from Hold at Argus

Target:$200.00

+20.0%from $166.73

Oct 17, 2025Mizuho Securities

Charles River price target raised to $174 from $155 at Mizuho

Target:$174.00

-0.5%from $174.95

Oct 3, 2025Evercore ISI

Charles River price target raised to $200 from $190 at Evercore ISI

Target:$200.00

+10.4%from $181.18

Oct 2, 2025Barclays

Charles River upgraded to Overweight from Equal Weight at Barclays

Target:$195.00

+14.4%from $170.48

Sep 9, 2025Jefferies

Charles River upgraded to Buy from Hold at Jefferies

Target:$195.00

+23.9%from $157.38

Oct 15, 2024Barclays

Charles River price target lowered to $205 from $210 at Barclays

Target:$205.00

+6.1%from $193.14

Oct 14, 2024Redburn Partners

Charles River initiated with a Sell at Redburn Atlantic

Target:$151.00

-21.7%from $192.97

Sep 17, 2024Mizuho Securities

Mizuho Reiterates Neutral Rating on Charles River Labs (CRL)

Target:$210.00

+1.7%from $206.44

Aug 8, 2024Deutsche Bank

Charles River price target lowered to $240 from $300 at Deutsche Bank

Target:$240.00

+19.8%from $200.34

Jul 10, 2024Robert W. Baird

Charles River price target lowered to $239 from $271 at Baird

Target:$239.00

+18.4%from $201.85

Jun 28, 2024Barclays

Barclays Starts Charles River Labs (CRL) at Equalweight

Target:$230.00

+10.9%from $207.35

Jun 6, 2024Goldman Sachs

Goldman Sachs Starts Charles River Labs (CRL) at Buy

Target:$290.00

+34.2%from $216.12

May 9, 2024Evercore ISI

Charles River Labs (CRL) PT Lowered to $265 at Evercore ISI

Target:$265.00

+15.2%from $230.09

Apr 1, 2024Evercore ISI

Charles River Labs (CRL) PT Raised to $300 at Evercore ISI

Target:$300.00

+10.7%from $270.95

May 5, 2022KeyBanc

Charles River Laboratories (CRL) Stock: $300 Price Target And Overweight Rating

Target:$300.00

+16.5%from $257.51

Apr 25, 2022Wells Fargo

Wells Fargo Maintains Overweight on Charles River, Lowers Price Target to $325

Target:$325.00

+26.1%from $257.75

Apr 25, 2022Jefferies

Charles River downgraded to Hold from Buy at Jefferies

Target:$280.00

+2.6%from $273.03

Jan 11, 2022Jefferies

Wall Street Analysts Are Bullish on Top Services Picks

Target:$464.00

+29.6%from $357.95

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance